Korean J Pain.  2012 Jul;25(3):198-199. 10.3344/kjp.2012.25.3.198.

Emerging Anti Carcinogenic Applications of Nimesulide: Therapeutic Benefits Beyond Its Primary Role in Pain Management

• Kapoor S

• KMID: 2278157
• DOI: http://doi.org/10.3344/kjp.2012.25.3.198

Abstract

No abstract available.

MeSH Terms

Pain Management

Reference

1. Saghaei E, Moini Zanjani T, Sabetkasaei M, Naseri K. Enhancement of antinociception by co-administrations of nefopam, morphine, and nimesulide in a rat model of neuropathic pain. Korean J Pain. 2012; 25:7–15. PMID: 22259710.

2. Zhang YJ, Bao YJ, Dai Q, Yang WY, Cheng P, Zhu LM, et al. mTOR signaling is involved in indomethacin and nimesulide suppression of colorectal cancer cell growth via a COX-2 independent pathway. Ann Surg Oncol. 2011; 18:580–588. PMID: 20803081.

3. Zhong B, Cai X, Yi X, Zhou A, Chen S, Su B. In vitro and in vivo effects of a cyclooxygenase-2 inhibitor nimesulide analog JCC76 in aromatase inhibitors-insensitive breast cancer cells. J Steroid Biochem Mol Biol. 2011; 126:10–18. PMID: 21458568.

4. Kim BM, Won J, Maeng KA, Han YS, Yun YS, Hong SH. Nimesulide, a selective COX-2 inhibitor, acts synergistically with ionizing radiation against A549 human lung cancer cells through the activation of caspase-8 and caspase-3. Int J Oncol. 2009; 34:1467–1473. PMID: 19360361.

5. Ambike V, Adsule S, Ahmed F, Wang Z, Afrasiabi Z, Sinn E, et al. Copper conjugates of nimesulide Schiff bases targeting VEGF, COX and Bcl-2 in pancreatic cancer cells. J Inorg Biochem. 2007; 101:1517–1524. PMID: 17689613.

6. Liu YJ, Ma YF, Zhang J, Zhao YP, Bai HL, Li SL. Synergistic lethal effect of mDRA-6 and nimesulide on human hepatocellular cancer cell line SMMC-7721. Ai Zheng. 2008; 27:374–378. PMID: 18423123.

7. Paul AG, Sharma-Walia N, Chandran B. Targeting KSHV/HHV-8 latency with COX-2 selective inhibitor nimesulide: a potential chemotherapeutic modality for primary effusion lymphoma. PLoS One. 2011; 6:e24379. PMID: 21980345.

8. Nimesulide: patients still exposed to a risk of severe hepatitis. Prescrire Int. 2011; 20:125–126. PMID: 21648177.